Your browser doesn't support javascript.
loading
PPARδ dysregulation of CCL20/CCR6 axis promotes gastric adenocarcinoma carcinogenesis by remodeling gastric tumor microenvironment.
Liu, Yi; Wei, Daoyan; Deguchi, Yasunori; Xu, Weiguo; Tian, Rui; Liu, Fuyao; Xu, Min; Mao, Fei; Li, Donghui; Chen, Weidong; Valentin, Lovie Ann; Deguchi, Eriko; Yao, James C; Shureiqi, Imad; Zuo, Xiangsheng.
Affiliation
  • Liu Y; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Wei D; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Deguchi Y; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Xu W; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Tian R; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Liu F; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Xu M; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Mao F; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Li D; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Chen W; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Valentin LA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Deguchi E; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Yao JC; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Shureiqi I; Rogel Cancer Center and Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, 48109, USA.
  • Zuo X; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. xzuo@mdanderson.org.
Gastric Cancer ; 26(6): 904-917, 2023 Nov.
Article de En | MEDLINE | ID: mdl-37572185
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'estomac / Adénocarcinome / Récepteur PPAR delta Type d'étude: Screening_studies Limites: Animals / Humans Langue: En Journal: Gastric Cancer Sujet du journal: GASTROENTEROLOGIA / NEOPLASIAS Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'estomac / Adénocarcinome / Récepteur PPAR delta Type d'étude: Screening_studies Limites: Animals / Humans Langue: En Journal: Gastric Cancer Sujet du journal: GASTROENTEROLOGIA / NEOPLASIAS Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique